Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.311,78
0,54%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Disc Medicine Inc (IRON) Disc Medicine Inc (IRON) Notizie

Disc Medicine Inc

IRON
64,96
1,46 (2,29%)
22 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
20/11/202400:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:47EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/11/202422:43EDGAR2Form POS AM - Post-Effective amendments for registration..
15/11/202422:39EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:31EDGAR2Form 8-K - Current report
14/11/202423:44EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:33EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202414:30GLOBEDisc Medicine to Participate in Upcoming Investor..
12/11/202414:00GLOBEDisc Medicine Reports Third Quarter 2024 Financial Results..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
08/11/202414:49EDGAR2Form 8-K - Current report
08/11/202414:30GLOBEDisc Medicine Secures $200 Million in Non-Dilutive Debt..
05/11/202415:00GLOBEDisc Medicine Announces Multiple Presentations Across..
04/11/202413:55EDGAR2Form 8-K - Current report
04/11/202413:50GLOBEDisc Medicine Announces Successful End of Phase 2 Meeting..
01/11/202421:01GLOBEDisc Medicine to Host Conference Call on End of Phase 2 FDA..
25/10/202419:11EDGAR2Form 8-K - Current report
25/10/202419:00GLOBEDisc Medicine Presents Positive Data from SAD Cohorts of a..
23/10/202414:00GLOBEDisc Medicine Appoints Seasoned Industry Executive Rahul..
11/10/202414:00GLOBEDisc Medicine Announces Presentation of New Data from Phase..
19/9/202414:30GLOBEDisc Medicine Expands Leadership Team with Appointment of..
18/9/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202422:39EDGAR2Form 144 - Report of proposed sale of securities
04/9/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:15EDGAR2Form 144 - Report of proposed sale of securities
30/8/202414:00GLOBEDisc Medicine to Participate in Upcoming Investor..
08/8/202415:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
08/8/202414:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202414:06EDGAR2Form 8-K - Current report
08/8/202414:00GLOBEDisc Medicine Reports Second Quarter 2024 Financial Results..
14/6/202422:08EDGAR2Form 8-K - Current report
14/6/202422:04EDGAR2Form 8-K - Current report
14/6/202422:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/6/202414:03GLOBEDisc Medicine Announces Underwritten Offering of Common..
14/6/202413:36EDGAR2Form 8-K - Current report
14/6/202413:30GLOBEDisc Medicine Presents Positive Clinical Data Across..
30/5/202415:00GLOBEDisc Medicine to Participate in the Jefferies Global..
14/5/202416:30GLOBEDisc Medicine Announces Multiple Presentations Across..
13/5/202414:00GLOBEDisc Medicine to Participate in the H.C. Wainwright..
09/5/202414:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:07EDGAR2Form 8-K - Current report
09/5/202414:00GLOBEDisc Medicine Reports First Quarter 2024 Financial Results..
01/4/202414:00GLOBEDisc Reports Topline Results from Phase 2 AURORA Study of..
21/3/202413:00GLOBEDisc Medicine Reports Fourth Quarter and Full Year 2023..
06/3/202422:30GLOBEDisc Medicine to Participate in the Leerink Partners Global..
02/3/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202401:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 63,34 Min: 62,61 Max: 65,80
Chiusura: 63,505

La tua Cronologia

NASDAQ
IRON
Disc Medicine
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network